Open now
 08045132036
DRUGCONSULTANTS
https://www.acplgroupindia.in
91

Chat with us on WhatsApp

×

Search

  1. Home
  2. Search results for "3 6 component"
Home / Search results for "3 6 component"

POLICY ON NEW DRUG APPLICATION: 1. The content of New Drug Application (NDA) should be des...

2023-10-28T05:47:16

View more

3. As per the rules, for manufacture or import of new drugs, the manufacturers/ importer a...

2023-10-28T05:42:42

View more

Accredited Consultants area of expertise varies from Compliance Certification ( BIS, WPC, ...

2024-03-19T05:08:56

View more

3. To enhance the communication aspects, CDSCO should ensure that the industry representat...

2023-10-30T06:21:42

View more

PRESENTATION AND SUBMISSION OF APPLICATION 1. In order to make regulatory review process a...

2023-10-30T06:19:04

View more

15.However, detailed guidance documents should be prepared providing the requirements and ...

2023-10-28T05:49:46

View more

10.As provided in the rules, surrogate marker should be considered as an interim data poin...

2023-10-28T05:49:20

View more

6. However, accelerated approval should be used for a drug that represent significant adva...

2023-10-28T05:47:30

View more

5. Clear policy on regulatory requirements, system and procedures is critical for efficien...

2023-10-28T05:39:56

View more

Subscribe for latest offers and updates.

we hate spam too